GNOM Price Forecast & ETF Analysis. Dividend · Expense Ratio · Holdings · NAV · RSI · MACD | US Stocks Today
October 7 at 4:10 PM ET (Korea 10/8 05:10)
Full metrics table
| Category | Global or ExUS Equities - Industry Sector | Expense | 0.5% | Return% 1Y | 67.38% | Total Holdings | 52 | Perf Week | -5.15% | Volume | 131,298 |
| Asset Type | Equities (Stocks) | AUM | $101M | Return% 3Y | 19.03% | NAV | $67.78 | Perf Month | 5.37% | Avg Volume | 0.03M |
| ETF Type | Global Equities | Dividend TTM | $0.65 (0.97%) | Return% 5Y | -5.1% | 52W High | -9.89% | Perf Quarter | 14.2% | Rel Volume | 4.28 |
| Active/Passive | Passive | Div Gr. 3/5Y | - | Return% 10Y | - | 52W Low | 66.42% | Perf Half Y | 48.45% | Prev Close | $67.60 |
| IPO | 2019/4/10 | Flows% 1M | 3.69% | Return% SI | 1.5% | RSI (14) | 49.75 | Perf YTD | 47.06% | Price | $66.85 |
| Beta | 1.22 | Flows% 3M | -2.76% | Flows% YTD | 23.42% | Flows% 1Y | 17.55% | Perf Year | 63.8% | Volatility(W/M) | 3.83% 2.64% |
| SMA20 | -0.94% | SMA50 | 4.83% | SMA200 | 28.5% | ATR | 2.1 | ||||
Global X Genomics & Biotechnology ETFGNOM | NASD | General ETF Global X Genomics & Biotechnology ETF seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Solactive Genomics Index ("underlying index"). The fund invests at least 80% of its total assets in the securities of the underlying index. The underlying index is designed to provide exposure to exchange-listed companies that are positioned to benefit from further advances in the field of genomic science and biotechnology, as well as applications thereof (collectively, "Genomics & Biotechnology Companies"), as defined by Solactive AG, the provider of the underlying index. The fund is non-diversified.
The top 10 make up 43% of the fund
GH GUARDANT HEALTH, INC. 5.59% 2 
ILMN ILLUMINA, INC. 4.82% 3 
NTRA NATERA, INC. 4.15% 4 
BMRN BIOMARIN PHARMACEUTICAL INC. 4.09% 5 
ARWR ARROWHEAD PHARMACEUTICALS, INC. 4.07% 6 
LEGN Legend Biotech Corp 4.05% 7 
PRAX Praxis Precision Medicines Inc 4.01% 8 
TWST Twist Bioscience Corp 3.97% 9 
VRTX VERTEX PHARMACEUTICALS INCORPORATED 3.95% 10 
CRSP CRISPR Therapeutics AG 3.85% Largest sectors first.
Over the past 1 year, on the higher side
10% below its 1-year high.
Traded more than usual That is 428% of its average volume.
Holding long would have lost money
Bought 5 years ago, your return today would be -23.3%. The S&P 500 did +77% over the same period.
Tap to view numbers
The price swings a lot
At its worst (February 2021) it fell 75% and has not fully recovered yet.
Tap to view numbers
The dividend is on the small side
Pays 0.97% annually in dividends.
Tap to view numbers
Money keeps flowing in
Over the past year, new money equal to 17.6% of assets came in.
Tap to view numbers
CURE Direxion Daily Healthcare Bull 3X ETF 157M 
RXL ProShares Ultra Health Care 2X Shares 92M 
XLVI State Street Health Care Select Sector SPDR Premium Income ETF 28M 
RXD-1× ProShares UltraShort Health Care -2x Shares 4M 
TBXU Direxion Daily Biotech Top 5 Bull 2X ETF 3M 
TRFK Pacer Data and Digital Revolution ETF 0.49% 
PPH VanEck Pharmaceutical ETF 0.36% 
NXTG First Trust Indxx NextG ETF 0.7% 
CLOU Global X Cloud Computing ETF 0.68% 
WQTM WisdomTree Quantum Computing Fund 0.45% 
HAUZ Xtrackers International Real Estate ETF 0.1% 
VNQI Vanguard Global ex-U.S. Real Estate ETF 0.12% 
PBPH Portfolio Building Block World Pharma and Biotech Index ETF 0.13% 
FAQ
How many holdings does GNOM have?
GNOM holds a total of 52 securities, with an AUM of approximately $101M.
Does GNOM pay dividends (distributions)?
GNOM's distribution yield is approximately 0.97%.
What is the 52-week high and low for GNOM?
GNOM has recorded a 52-week high of $74.19 and a low of $40.17.
